Clinical and Histologic Features of Azithromycin-Induced Liver Injury
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background & Aims Rare cases of azithromycin-induced hepatotoxicity have been reported, with variable clinical and histological features. We characterized clinical features and outcomes of azithromycin-induced liver injury. Methods We identified patients with azithromycin-induced liver injury from the Drug-Induced Liver Injury Network Prospective Study who had causality scores of definite, highly likely, or probable. Demographic, clinical, and laboratory data and 6-month outcomes were examined. Results Eighteen patients (72% female; mean age, 37 years) had causality scores of definite (n=1), highly likely (n=9), or probable (n=8). Common presenting symptoms were jaundice, abdominal pain, nausea, and/or pruritus. For 16 patients, abnormal results from liver tests were first detected 14 days after azithromycin cessation (range, 9–20 days). The median duration of azithromycin treatment was 4 days (range, 2–7 days). The pattern of injury was hepatocellular in 10 patients, cholestatic in 6 patients, and mixed in 2 patients. The mean peak level of alanine aminotransferase was 2127 IU/L, of alkaline phosphatase was 481 IU/L, and of total bilirubin was 9.2 mg/dL. Liver histology showed ductopenia and veno-occlusive changes in a few cases. Two individuals had severe hypersensitivity cutaneous reactions. After 6 months, 8 patients had recovered, 4 had chronic injury, 1 died, and 1 underwent liver transplantation (outcomes were unavailable for 4 patients). Two of the patients with fatal or liver transplantation outcomes had preexisting chronic liver disease. Conclusions Azithromycin-induced liver injury occurs within 1–3 weeks after azithromycin initiation and is predominantly hepatocellular in nature. Although most patients recover fully, severe cutaneous reactions, chronic injury, and serious complications leading to death or liver transplantation can occur (ClinicalTrials.gov identifier, NCT00345930).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Timing of new black box warnings and withdrawals for prescription medications
Lasser, K. E. (2002) · JAMA · doi:10.1001/jama.287.17.2215 · Cited by 1,005
Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study
Reuben, A., Koch, D. G., & Lee, W. M. (2010) · Hepatology · doi:10.1002/hep.23937 · Cited by 772
U.S. Outpatient Antibiotic Prescribing, 2010
Hicks, L. A., Taylor, T. H., & Hunkler, R. J. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1212055 · Cited by 247
Antibiotic-Induced Liver Toxicity: Mechanisms, Clinical Features and Causality Assessment
Robles, M., Toscano, E., Cotta, J., Isabel Lucena, M., & J. Andrade, R. (2010) · Current Drug Safety · doi:10.2174/157488610791698307 · Cited by 45
Cited by
Drug-induced liver injury—types and phenotypes
Hoofnagle, J. H., & Björnsson, E. S. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1816149 · Cited by 652
Self-citationCSH guidelines for the diagnosis and treatment of drug-induced liver injury
Drug-induced Liver Injury (DILI) Study Group, Yu, Y.-C., Chinese Society of Hepatology (CSH), Chinese Medical Association (CMA), Mao, Y.-M., Chen, C.-W., Chen, J.-J., Chen, J., Cong, W.-M., Ding, Y., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9793-2 · Cited by 254
Sundaram, V., & Björnsson, E. S. (2017) · Hepatology Communications · doi:10.1002/hep4.1088 · Cited by 138
Death and liver transplantation within 2 years of onset of drug‐induced liver injury
Hayashi, P. H., Rockey, D. C., Fontana, R. J., Tillmann, H. L., Kaplowitz, N., Barnhart, H. X., Gu, J., Chalasani, N. P., Reddy, K. R., Sherker, A. H., et al. (2017) · Hepatology · doi:10.1002/hep.29283 · Cited by 123
Self-citationDrug-induced liver injury: Highlights from a review of the 2015 literature
Sarges, P., Steinberg, J. M., & Lewis, J. H. (2016) · Drug Safety · doi:10.1007/s40264-016-0427-8 · Cited by 74
Metadata
- Authors
- Martinez, M. A., Vuppalanchi, R., Fontana, R. J., Stolz, A., Kleiner, D. E., Hayashi, P. H., Gu, J., Hoofnagle, J. H., & Chalasani, N.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 13
- Issue
- 2
- Pages
- 369-376.e3
- ISSN
- 1542-3565 (ISSN-L)
- OpenAlex
- W2083442763
- Cited by
- 132
- References
- 4
- FWCI
- 7.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical and Histologic Features of Azithromycin-Induced Liver Injury. https://app.cochat.ai/papers/10.1016/j.cgh.2014.07.054
- The paper
- Martinez, M. A., Vuppalanchi, R., Fontana, R. J., Stolz, A., Kleiner, D. E., Hayashi, P. H., Gu, J., Hoofnagle, J. H., & Chalasani, N. (2015). Clinical and Histologic Features of Azithromycin-Induced Liver Injury. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2014.07.054
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.